TuHURA Biosciences (HURA) Net Equity Issued and Repurchased (2013 - 2026)

TuHURA Biosciences' Net Equity Issued and Repurchased history runs 5 years deep, the most recent figure standing at $7.5 million for Q1 2026.

• In Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $7.5 million; the TTM figure through Mar 2026 stood at $24.9 million (changed N/A YoY), while the FY2025 annual figure was $18.3 million, up 266.07% from the prior year.
• Net Equity Issued and Repurchased for Q1 2026 stood at $7.5 million, up from $6.2 million in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $10.5 million in Q1 2024, with the low at $105000.0 in Q4 2023.
• The 4-year median for Net Equity Issued and Repurchased is $6.2 million (2025), against an average of $5.9 million.
• Peak annual rise in Net Equity Issued and Repurchased reached 23.95% in 2025, while the deepest fall reached 23.95% in 2025.
• TuHURA Biosciences' Net Equity Issued and Repurchased stood at $105000.0 in 2023, then jumped by 4661.9% to $5.0 million in 2024, then increased by 23.82% to $6.2 million in 2025, then gained by 21.14% to $7.5 million in 2026.
• Business Quant data shows HURA's Net Equity Issued and Repurchased at $7.5 million in Q1 2026, $6.2 million in Q4 2025, and $6.2 million in Q3 2025.